Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-816-9 | CAS number: 17865-07-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Read-across from experimental results with supporting substances acetic acid and sodium acetate:
In vitro gene mutation in bacteria: Weight of evidence:
In the study by Zeiger et. al., 1992 (reliability 1), bacterial reverse mutation assay (Ames test) according to OECD Guideline 471 and with GLP compliance was performed. A standard Ames test was carried out with acetic acid using Salmonella typhimurium strains TA 98, TA 100, TA 1535, and TA 97, with and without metabolic activation. Acetic acid did not show any mutagenic effect under test conditions. Based on these experimental results, read-across approach was applied and propyltriacetoxysilane was also considered as no mutagenic under test conditions.
In the study by McMahon et. al., 1979 (reliability 2), bacterial reverse mutation assay (Ames test) according to OECD Guideline 471 (with deviations) was performed. A bacterial mutagen screening technique was carried out with acetic acid using Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, with and without metabolic activation. Acetic acid did not show any mutagenic effect under test conditions. Based on these experimental results, read-across approach was applied and propyltriacetoxysilane was also considered as no mutagenic under test conditions.
In the study by Ishidate et. al., 1984 (reliability 2), bacterial reverse mutation assay (Ames test) according to OECD Guideline 471 (with deviations) was performed. The study was carried out with sodium acetate and using Salmonella typhimurium strains TA92, TA1535, TA100, TA1537, TA94, only with metabolic activation. No significant increases in the numbers of revertant colonies were detected at the maximum dose tested. Based on these experimental results, read-across approach was applied and propyltriacetoxysilane was also considered as no mutagenic under test conditions.
In vitro mammalian chromosome aberration. Weight of evidence:
In the study by Morita et. al., 1990 (reliability 2), a cytogenetic assay was carried out with acetic acid using Chinese hamster ovary K1 cells. Acetic acid was not clastogenic at concentrations close to those showing cytotoxicity, both with and without metabolic activation. Low pH did induce some artificial chromosome aberrations, but these were eliminated by neutralization of the test medium. Based on these experimental results and applying the read-across approach, the substance propyltriacetoxysilane is also considered as not clastogenic under test conditions.
In the study by Ishidate et. al., 1983 (reliability 2), a chromosomal aberrations tests were carried out with sodium acetate using a Chinese hamster fibroblast cell line. In the studies, no metabolic activation systems were applied. The maximum dose of each sample was selected by a preliminary test in which the dose needed for 50% cell-growth inhibition was estimated using a cell densiometer. The incidence of cells with aberrations (including gaps) was 0%. Based on these experimental results, the read-across approach was applied and propyltriacetoxysilane was also considered as no mutagenic under test conditions.
In vitro gene mutation in mammalian cells. Experimental results on propyltriacetoxysilane. Key study:
The test item Propyl Triacetoxy Silane PTA was assessed for its potential to induce mutations at the mouse lymphoma thyamidine kinase locus using the cell line L5178Y according to OECD Guideline 476. The Experiment I was performed as a 4h short-term exposure assay up to 10.0 mM (with metabolic activation) and up to 5.5 mM (without metabolic activation). The Experiment II was performed as a 4h short-term exposure up to 8.5 mM (with metabolic activation) and a 24h long-term exposure up to 5.0 mM (without metabolic activation). No biologically relevant increase of mutants was found after treatment with the test item. Additionally, colony sizing showed no clastogenic effects induced by the test item. Therefore, Propyl Triacetoxy Silane (PTA) was considered to be non-mutagenic in the in vitro mammalian cell gene mutation assay (thymidine kinase locus) in mouse lymphoma L5178Y cells with and without metabolic activation under test conditions.
Read-across from experimental results with supporting substance sodium acetate:
In vivo genetic toxicity. Key study:
In the study by Seiler, 1981 (reliability 2), the Testicular DNA-synthesis inhibition test (DSI test) was performed on male mice with Sodium Acetate (single oral dose by gavage). No inhibitory effect on DNA-replication was detectable in animals treated with Sodium Acetate. Based on these results, read-across approach was applied and propyltriacetoxysilane is also considered no genotoxic in animals (based on no effects on DNA-replication).
Justification for selection of genetic toxicity endpoint
No study was selected, since all available studies were negative.
Short description of key information:
In vitro bacteria reverse mutation and in vitro mammalian chromosome aberration: Weight of evidence: Experimental results from studies performed with the supporting substances acetic acid and sodium acetate. All study results were negative. Based on these results, the read-across approaches were applied and propyltriacetoxysilane is considered negative under test conditions.
In vitro gene mutation in mammalian cells: Key study: Propyl Triacetoxy Silane (PTA) was considered to be non-mutagenic in the in vitro mammalian cell gene mutation assay (thymidine kinase locus) in mouse lymphoma L5178Y cells under test conditions.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available information on genetic toxicity in vitro (Bacterial Reverse Mutation Assay, Chromosome Aberration and Gene Mutation Tests) and in vivo (DNA damage genotoxicity test) the substance propyltriacetoxysilane is considered to be negative, and therefore, the substance is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.